Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

BACKGROUND: Investigate the impact of the reduction of the number of target lesions on immune-related response assessment in advanced melanoma patients treated with ipilimumab. METHOD: Ninety patients (53 males, 37 females; age range: 25–87) with advanced melanoma treated with ipilimumab in two clin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nishino, Mizuki, Gargano, Maria, Suda, Margaret, Ramaiya, Nikhil H, Hodi, F Stephen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077549/
https://ncbi.nlm.nih.gov/pubmed/24991412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-17
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky